FLUAD QUADRIVALENT Drug Insight and Market Forecasts, 2019-2032: Focus on 6MM - United States, Germany, France, Italy, Spain and United Kingdom
December 12, 2023 04:53 ET
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUAD QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
FLUBLOK: A Quadrivalent Influenza Vaccine for Adults Aged 18 and Older - Drug Insights and Market Forecast to 2032
December 12, 2023 04:48 ET
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This "FLUBLOK QUADRIVALENT...
Global Respiratory Disease Vaccine Research Report 2023: A $70+ Billion Industry by 2030 - Increasing Prevalence and Growing Focus on Prevention Bolsters Growth
December 12, 2023 03:13 ET
|
Research and Markets
Dublin, Dec. 12, 2023 (GLOBE NEWSWIRE) -- The "Respiratory Disease Vaccine Market Size, Share & Trends Analysis Report By Type (Viral, Bacterial, Combination), By Age Group, By Infection...
Microbial Fermentation Technology Market revenue to hit USD 63 Billion by 2036, says Research Nester
December 06, 2023 06:00 ET
|
Research Nester
New York , Dec. 06, 2023 (GLOBE NEWSWIRE) -- The global microbial fermentation technology market size is expected to expand at 6% CAGR from 2024 to 2036. The market is anticipated to garner a...
VAX-24 Phase 1/2 Adult Proof-of-Concept Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 24-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
December 04, 2023 18:35 ET
|
Vaxcyte, Inc.
-- In the Study, VAX-24 Demonstrated a Safety and Tolerability Profile Similar to Prevnar 20® (PCV20) at all Doses Studied -- -- All 24 Serotypes of VAX-24 at Conventional 2.2 mcg PCV Dose Met or...
Protein Engineering Market Size to Reach USD 11.22 Billion in 2032 | Emergen Research
December 04, 2023 08:52 ET
|
Emergen Research
Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) -- The global Protein Engineering Market is expected to reach USD 11.22 Billion by 2032, according to a new report by Emergen Research. The growth of this...
EBViously Presents Novel In-Vitro Data Demonstrating Potent Infection Prevention of its Vaccine Candidate EBV-001
December 04, 2023 04:00 ET
|
AKAMPION
Presentation at the World Vaccine Congress West Coast2023EBV-001 is designed for the prevention of Epstein-Barr Virus (EBV)-induced diseases via high titers of potent, neutralizing antibodiesNovel...
Vaccines Market to Hit USD 99.3 billion by 2031, at a CAGR 4.2% | Says Transparency Market Research, Inc.
December 01, 2023 07:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global vaccines market was estimated at a value of US$ 119.1 billion in 2022. It is...
mRNA Platform Market Research Report 2023 - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F
December 01, 2023 06:18 ET
|
Research and Markets
Dublin, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The "mRNA Platform Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F" report has been added to ResearchAndMarkets.com's...
Dyadic Attends Investor Events in December
November 30, 2023 08:30 ET
|
Dyadic International, Inc.
Dyadic Attends Investor Events in December